Acquisition

The tapered glass Salesforce Tower rising above neighbouring office buildings in downtown San Francisco under a blue sky.

Salesforce Will Pay $47.50 a Share in Cash for Braze, an Enterprise Value of About $5.66 Billion. It Has Agreed to a $300 Million Reverse Termination Fee.

Salesforce said on Tuesday 20 October that it has signed a definitive agreement to buy Braze for $47.50 in cash per Class A share, an enterprise value of about $5.66 billion. Closing is expected in Salesforce's fiscal 2028 and needs a Braze shareholder vote and regulatory approvals.

By Alison Acosta October 20, 2026

A glass office building and an older building with a tiled roof around a paved plaza, with a large blue Merck sign standing on the plaza.

Health

Merck KGaA Will Pay $20 an ADS in Cash for Silence Therapeutics, a 130 Per Cent Premium. The Price Is Built on One Drug, Not Yet in Phase 3.

Merck KGaA of Darmstadt, Germany, agreed on 19 October to buy Silence Therapeutics for $20.00 in cash per American depositary share, an equity value of about $1.3 billion and an enterprise value of $1.1 billion. The deal is expected to close in the first quarter of 2027 and still needs shareholder, court and regulatory approval.

By Thomas Gutierrez 28 hours ago

Acquisition

Tagged stories

Salesforce Will Pay $47.50 a Share in Cash for Braze, an Enterprise Value of About $5.66 Billion. It Has Agreed to a $300 Million Reverse Termination Fee.

Merck KGaA Will Pay $20 an ADS in Cash for Silence Therapeutics, a 130 Per Cent Premium. The Price Is Built on One Drug, Not Yet in Phase 3.